Key Highlights

  • Phaos Technology reported fiscal 2026 Revenue of about $104,000, down 21%, with a net loss of about S$6.16 million and a going-concern warning disclosed in its August 2026 annual report.
  • Innoviz Technologies reported Q2 2026 revenue of $18.1 million, up 86% year-over-year, and reaffirmed 2026 guidance for revenue of $67 million to $73 million.
  • Phaos shareholders approved a 15-for-1 share consolidation on August 31, 2026 after the stock experienced unexplained sharp single-day declines in February and May 2026.
  • Innoviz raised about $30 million in a registered direct offering in July 2026, Earmarking proceeds partly for its new Perciz defense and homeland security brand, which has received initial orders of $3.5 million.

Both Phaos Technology (NYSE American:POAS) and Innoviz Technologies (NASDAQ:INVZ) build products that depend on light. Phaos, based in Singapore, sells optical microscopy systems that it says can resolve features below the conventional limit of light microscopes. Innoviz, based in Israel, makes LiDAR sensors that use laser pulses to map the surroundings of cars, trucks and, increasingly, defense and security systems. Both are small, loss-making and trading at share prices that have created listing pressure, but the differences are larger than the similarities.

Phaos Technology (NYSE American:POAS): An Early-Stage Microscopy Maker

Phaos Technology Holdings went public in November 2025, pricing 3.6 million shares at $4.00, the low end of its range, for proceeds of about $14 million. Its shares trade on NYSE American rather than Nasdaq. Through its Singapore subsidiary, the company assembles and sells microscopy products, including its Optonano imaging line and industrial and metrology systems, aimed at manufacturing, semiconductor and biomedical users. Its IPO materials highlighted patented microsphere-assisted technology and super-resolution imaging down to 137 nanometers.

Commercial traction so far is very limited. In its Annual Report on Form 20-F for the fiscal year ended April 30, 2026, filed August 31, 2026, Phaos reported revenue of S$132,077 (about US$104,000), down 21% from S$167,707 the prior year, and a net loss of about S$6.16 million, compared with S$5.14 million. Singapore generated 86% of revenue, and the top five customers accounted for 81%, with the largest at 38%. The filing includes a going-concern warning, identifies material weaknesses in internal controls, and discloses the write-off of a S$1.6 million Loan to a biomedical software developer.

Corporate events have been frequent. The chief executive resigned at the end of 2025 and an interim CEO was appointed. The 20-F notes sharp single-day share-price declines in February and May 2026 without disclosed changes in the business. At an August 31, 2026 extraordinary general meeting, shareholders approved a 15-for-1 share consolidation, an increase in authorized Share Capital and the issuance of new shares.

Innoviz Technologies (NASDAQ:INVZ): Automotive LiDAR Pushing Into Defense

Innoviz supplies automotive-grade LiDAR sensors and perception software, and lists Volkswagen, Mobileye and Daimler Truck among the programs it is working toward production with. In its August 5, 2026 release, the company reported second-quarter 2026 revenue of $18.1 million, up 86% from $9.7 million a year earlier, though first-half revenue of $25.2 million was slightly below the $27.1 million of the first half of 2025. Gross Margin in the quarter was 3.9%, and the first-half net loss was $44.7 million versus $31.1 million.

At June 30, 2026, Innoviz held $48.5 million in cash, bank deposits and marketable securities. It then raised about $30 million in a registered direct offering of 66.7 million shares that closed on July 29, 2026, earmarking proceeds in part for Perciz, its new defense and homeland security brand, which has received initial orders of $3.5 million. The company reaffirmed 2026 guidance for revenue of $67 million to $73 million, two to three new program wins and $20 million to $30 million in engineering service contracts.

Innoviz also has a listing issue to resolve. It received a Nasdaq minimum bid price notice in March 2026, and a September 23, 2026 filing disclosed a second 180-day period, to March 22, 2027. Shareholders approved authority for a reverse share split on September 16, 2026.

What Separates Them: Scale and Commercial Stage

The clearest dividing line is scale. Innoviz's quarterly revenue is well over a hundred times Phaos's annual revenue, and it works with global automakers under multi-year programs. Phaos remains an early-stage company whose revenue is concentrated among a handful of regional customers. The shared challenge is margin: neither Business has yet shown that its optical technology can be produced and sold profitably at volume.

  • Revenue trajectory: Can Innoviz deliver the second-half growth implied by its guidance, and can Phaos show any sustained sales growth?
  • Gross margin: Does Innoviz's single-digit margin improve as programs move toward production?
  • Customer breadth: Does Phaos reduce its reliance on a few Singapore customers?
  • Share structure: How do the Phaos consolidation and any Innoviz reverse split change share counts and liquidity?

Using the Nasdaq Composite as a Benchmark

The Nasdaq Composite offers a broad measure of how technology-heavy stocks are performing. Comparing each company's returns and Volatility with the index over the same period helps separate market-wide mood from company-specific events such as financings, consolidations or Earnings surprises. For Phaos, which trades on NYSE American, the index serves purely as an external yardstick for technology sentiment.

The index is used here as a comparison benchmark only; nothing here implies that either company is a member. Microcaps typically move far more sharply than broad indexes, and share consolidations or dilutive offerings can produce price swings that have little to do with the overall market.

Risks

For Phaos, the risks are fundamental: minimal and declining revenue, heavy customer concentration, a going-concern warning, internal control weaknesses, Leadership turnover and approved authority to issue new shares that could dilute existing holders.

Innoviz faces a different set: a very thin gross margin, continued losses, reliance on the timing of automaker production launches, and Equity raises that expand its share count. Its defense push is new and its early orders are small relative to the business.

Opposite Ends of the Optical Commercialization Curve

Phaos Technology and Innoviz Technologies both turn optical science into products, but they sit at opposite ends of the commercialization curve. Innoviz has meaningful revenue, major automotive customers and a new defense channel, balanced against slim margins and ongoing dilution. Phaos is an early-stage microscopy company with very small revenue and substantial going-concern and governance questions.